Related Experiment Video
Updated: Feb 27, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Characterization of the hypercoagulable state in patients with sickle cell disease
Nirmish Shah1, Courtney Thornburg, Marilyn J Telen
1Division of Hematology/Oncology, Department of Pediatrics, Duke University, Durham, NC, USA. nirmish.shah@duke.edu
Insights
Sickle cell disease (SCD) patients show higher thrombin generation and D-dimer levels during vaso-occlusive crisis (VOC) compared to steady state. These hypercoagulable markers indicate increased thrombotic risk but do not correlate with specific clinical outcomes.
Area of Science:
- Hematology
- Thrombosis Research
- Vascular Biology
Background:
- Sickle cell disease (SCD) is characterized by a complex pathophysiology.
- A prothrombotic state is increasingly recognized as a significant factor in SCD.
Purpose of the Study:
- To investigate thrombin generation in SCD patients using calibrated automated thrombography (CAT) and D-dimer.
- To correlate these hypercoagulable markers with clinical disease manifestations.
Main Methods:
- Studied 51 patients with homozygous hemoglobin S, including those in vaso-occlusive crisis (VOC) and steady state.
- Utilized calibrated automated thrombography (CAT) and D-dimer assays.
- Correlated findings with clinical outcomes like avascular necrosis, stroke, hospitalizations, and transcranial Doppler (TCD) velocities in pediatric patients.
Main Results:
- Significantly higher D-dimer levels were observed during VOC compared to steady state (p<0.0001).
- CAT analysis revealed significant differences in thrombin generation phases between crisis and steady state (p<0.0001).
- In pediatric patients, increased TCD velocities correlated with steady state D-dimer and thrombin-antithrombin complex (p<0.05).
Conclusions:
- Hypercoagulable markers effectively differentiate SCD patients during and between VOC.
- These markers do not show correlation with specific clinical phenotypes in SCD patients.
Background:
The pathophysiology of sickle cell disease (SCD) is complex, with increasing evidence of a pronounced prothrombotic state.
Objective:
We investigated thrombin generation in SCD utilizing calibrated automated thrombography (CAT) and D-dimer, with subsequent correlation to clinical disease.
Patient/Methods:
The study included 51 patients homozygous for hemoglobin S, either admitted for vaso-occlusive crisis (VOC) (n=34) or while in steady state and being seen in outpatient clinic (n=37). Twenty patients had blood drawn during both VOC and steady state. Mean values for CAT and D-dimer were compared between groups. Mean values for patients with and without clinical complications such as avascular necrosis and stroke were also compared. Linear regression was used to evaluate correlation to number of hospitalizations and for all pediatric patients, transcranial doppler (TCD) velocities.
Results:
The mean D-dimer during VOC (2743 ± 3118 ng/ml) was significantly higher than during steady state (1151 ± 802, p<0.0001). Comparison of crisis and steady state by CAT also revealed a significant difference in all phases of thrombin generation, including mean endogenous thrombin potential (1381 ± 295 nM vs 923 ± 316, p<0.0001) and peak thrombin generated (284 ± 9 vs 223 ± 18, p=0.0002). There were no significant differences in mean values for the clinical outcomes examined in adults. In pediatric patients, however, increased TCD velocities correlated with steady state D-dimer (r(2)=0.32, p=0.02) and thrombin-antithrombin complex (r(2)=0.28, p=0.04.
Conclusion:
Hypercoagulable markers distinguish between patients with SCD during and between VOC, but do not correlate with specific clinical phenotypes.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Multiple Allele Traits
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

